[go: up one dir, main page]

WO2005041886A3 - Procedes permettant de generer ou d'augmenter des revenus lies au commerce des inhibiteurs de la douleur - Google Patents

Procedes permettant de generer ou d'augmenter des revenus lies au commerce des inhibiteurs de la douleur Download PDF

Info

Publication number
WO2005041886A3
WO2005041886A3 PCT/US2004/036186 US2004036186W WO2005041886A3 WO 2005041886 A3 WO2005041886 A3 WO 2005041886A3 US 2004036186 W US2004036186 W US 2004036186W WO 2005041886 A3 WO2005041886 A3 WO 2005041886A3
Authority
WO
WIPO (PCT)
Prior art keywords
generating
commerce
methods
pain inhibitor
increasing revenues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2004/036186
Other languages
English (en)
Other versions
WO2005041886A2 (fr
Inventor
Daniela Salvemini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Metaphore Pharmaceuticals Inc
Original Assignee
Metaphore Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metaphore Pharmaceuticals Inc filed Critical Metaphore Pharmaceuticals Inc
Publication of WO2005041886A2 publication Critical patent/WO2005041886A2/fr
Anticipated expiration legal-status Critical
Publication of WO2005041886A3 publication Critical patent/WO2005041886A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne une méthode permettant de fournir un service consistant à identifier un inhibiteur de nitration qui permet de traiter, prévenir ou inhiber la douleur et de préparer une forme posologique thérapeutiquement efficace dudit inhibiteur de nitration. L'invention concerne également une méthode qui permet de générer un revenu.
PCT/US2004/036186 2003-10-31 2004-10-31 Procedes permettant de generer ou d'augmenter des revenus lies au commerce des inhibiteurs de la douleur Ceased WO2005041886A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51620603P 2003-10-31 2003-10-31
US60/516,206 2003-10-31

Publications (2)

Publication Number Publication Date
WO2005041886A2 WO2005041886A2 (fr) 2005-05-12
WO2005041886A3 true WO2005041886A3 (fr) 2006-07-20

Family

ID=34549503

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/036186 Ceased WO2005041886A2 (fr) 2003-10-31 2004-10-31 Procedes permettant de generer ou d'augmenter des revenus lies au commerce des inhibiteurs de la douleur

Country Status (1)

Country Link
WO (1) WO2005041886A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8598150B1 (en) 2008-04-02 2013-12-03 Jonathan R. Brestoff Composition and method for affecting obesity and related conditions
US8987245B2 (en) 2008-04-02 2015-03-24 Jonathan R. Brestoff Parker Composition and method for affecting obesity and related conditions
BR112013033562A2 (pt) 2011-08-25 2017-02-14 Hoffmann La Roche proteína de fusão de tetranectina-apolipoproteína a-i encurtada, uma partícula de lipídio que a contém e uso das mesmas
US9757395B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
US9757529B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
US10149823B2 (en) 2013-04-30 2018-12-11 Otitopic Inc. Dry powder formulations and methods of use
CN115919780A (zh) 2017-09-22 2023-04-07 维克图拉公司 含有硬脂酸镁的干粉组合物
US10786456B2 (en) 2017-09-22 2020-09-29 Otitopic Inc. Inhaled aspirin and magnesium to treat inflammation

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6284794B1 (en) * 1996-11-05 2001-09-04 Head Explorer Aps Method for treating tension-type headache with inhibitors of nitric oxide and nitric oxide synthase
US20020128248A1 (en) * 1997-06-20 2002-09-12 Metaphore Pharmaceuticals, Inc SODm therapy for prevention and/or treatment of inflammatory disease

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6284794B1 (en) * 1996-11-05 2001-09-04 Head Explorer Aps Method for treating tension-type headache with inhibitors of nitric oxide and nitric oxide synthase
US20020128248A1 (en) * 1997-06-20 2002-09-12 Metaphore Pharmaceuticals, Inc SODm therapy for prevention and/or treatment of inflammatory disease

Also Published As

Publication number Publication date
WO2005041886A2 (fr) 2005-05-12

Similar Documents

Publication Publication Date Title
PT1509232E (pt) Uma combinação de um antagonista de nmda e inibidores da acetilcolina esterase para o tratamento da doença de alzheimer
WO2005000213A3 (fr) Methode permettant de traiter des maladies a l'aide d'agent d'inhibition hsp90 combines a des inhibiteurs d'enzymes
WO2006044825A3 (fr) Inhibiteurs de la kinesine mitotique et methodes d'utilisation desdits inhibiteurs
AU7321598A (en) Use of cholinesterase inhibitors to treat disorders of attention
WO2002053187A3 (fr) Methodes et compositions transdermiques pour le soulagement de la douleur
WO2005120461A3 (fr) Formulations liposomales renfermant de la dihydrosphingomyeline, et procedes d'utilisation correspondants
WO2002038142A3 (fr) Compositions serotoninergiques et methodes de traitement de la deficience cognitive legere
WO2004091540A3 (fr) Methodes de traitement de la douleur et compositions associees
WO2004062624A3 (fr) Methode pour traiter des nausees, des vomissements, des haut-le-coeur ou une association de ces symptomes
WO2003006893A3 (fr) Procedes inhibant la toxicite amyloide
WO2001056573A8 (fr) Utilisation d'inhibiteurs de cox-2 en tant qu'agents procinetiques gastriques
WO2005041864A3 (fr) Technique de traitement de prevention d'inflammation respiratoire avec un inhibiteur de cyclooxygenase-2 combine a un inhibiteur de phosphodiesterase 4 et compositions a partir de ceux-ci
AU2003294590A1 (en) A method for the treatment, prevention, or inhibition of a cns disorder and/or pain and inflammation using a combination of duloxetine, venlafaxine or atomoxetine and a cyclooxygenase-2 selective inhibitor and compositions thereof
WO2001087343A3 (fr) Polytherapie faisant appel a un inhibiteur selectif de cox-2 et a un inhibiteur de la thromboxane ainsi que des compositions contenant ceux-ci
WO2003092606A3 (fr) Inhibiteurs de cholinesterase pour prevenir les blessures causees par des produits chimiques
WO2005041886A3 (fr) Procedes permettant de generer ou d'augmenter des revenus lies au commerce des inhibiteurs de la douleur
WO2001097794A8 (fr) Decouverte a l'aide d'une structure d'inhibiteurs de matriptase destines au traitement du cancer et d'autres pathologies
TW200503666A (en) Treatment of type 1 diabetes with pde5 inhibitors
EP0870502A3 (fr) Utilisation d'inhibiteurs de l'assimilation d'adénosine pour la fabrication d'un médicament pour le traitement de la pancréatite
WO2007044325A3 (fr) Inhibiteurs de l'interaction du domaine apoe4 et methodes d'utilisation
WO1999065475A3 (fr) Combinaison de phentolamine et apomorphine pour le traitement concernant les fonctions et les dysfonctionnements sexuels
WO2004060878A3 (fr) Inhibiteurs de phosphatases
HRP20030892A2 (en) Prevention of addiction in pain management
BRPI0416202A (pt) formulações inibidoras de fosfodiesterase v
WO2002096516A8 (fr) Compositions d'inhibiteurs selectifs de cyclooxygenase-2 et rayonnement pour l'inhibition ou la prevention de maladies cardiovasculaires

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DPEN Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101)
122 Ep: pct application non-entry in european phase